Hostname: page-component-5c6d5d7d68-lvtdw Total loading time: 0 Render date: 2024-08-19T02:48:32.290Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbamazepine in affective disorders

Published online by Cambridge University Press:  02 January 2018

Denis J. Murphy ,
Rajender Kumar  and
Aiden McGennis
Denis J. Murphy
Affiliation:
Clinical Headquarters, “Cois Cuain”, 140 St Laurence's Road, Clontarf, Dublin 3
Rajender Kumar
Affiliation:
Clinical Headquarters, “Cois Cuain”, 140 St Laurence's Road, Clontarf, Dublin 3
Aiden McGennis
Affiliation:
Clinical Headquarters, “Cois Cuain”, 140 St Laurence's Road, Clontarf, Dublin 3
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 156 , Issue 2 , February 1990 , pp. 282 - 283
Copyright
Copyright © Royal College of Psychiatrists, 1990

References

Frankenburg, F. R., Tohen, M., Cohen, B. M., et al (1988) Long term response to carbamazepine: a retrospective study. Journal of Clinical Psychopharmacology, 8, 130–132.CrossRefGoogle ScholarPubMed
Watkins, S. E., Callender, K., Thomas, D. F., et al (1987) The effect of carbamazepine and lithium on remission from affective disorder. British Journal of Psychiatry, 150, 180–182.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.